Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Aprecia Expands Capacity for 3D-Printed Dosage Manufacturing

February 24, 2015

Aprecia Pharmaceuticals' new facility in Ohio will create 150 jobs.

BMS Furthers its Immuno-Oncology Pipeline with Nearly $1.6 Billion in Investments

February 23, 2015

Bristol-Myers Squibb announced that it reached an agreement to acquire Flexus Biosciences and has entered into a $309-million partnership with Rigel Pharmaceuticals.

Celltrion Announces that Remicade Biosimilar Could Save Up to $380 Million USD

February 23, 2015

Celltrion announced that its Remicade biosimilar, Rensima, could save France, Italy, and the UK up to €336 million in costs to treat Crohn’s disease.

Cell Medica Begins Commercial Manufacturing of Cell Therapies

February 19, 2015

The Berlin-Buch facility will begin manufacture of the company’s immune cell therapy.

Single-use Purification Media Improves Efficiency

February 18, 2015

The all-synthetic 3M Emphaze AEX Hybrid Purifier contains both an anion-exchange nonwoven media and a fine-particle, bioburden reduction membrane.

Rotary Capsule Filler Reduces Product Loss

February 18, 2015

MG America's TEKNA Capsule Filler has advanced controls to reduce powder loss and maintain optimal performance.

First Hospira Biosimilar mAb Approved in West Europe

February 17, 2015

Hospira’s Inflectra (infliximab), a biosimilar for Remicade, is approved by the European Commission.

New Financial Strategies Needed to Support Biomedical Innovation

February 17, 2015

The ongoing battle over drug reimbursement and pricing has raised questions about whether the pharmaceutical industry can continue to rely on high United States revenues to fund biopharmaceutical R&D.

CDER and Biotech Quality Assessment

February 11, 2015

The Center for Drug Evaluation and Research seeks a more flexible system for assessing biotech product quality.

Pfenex Announces Partnership with Hospira to Develop Lucentis Biosimilar

February 11, 2015

Pfenex announced that it entered into an agreement to partner with Hospira on the development and commercialization of PF582, a biosimilar candidate to Lucentis.